Reducing the incidence in melanoma incidence by 2005 is an important Health of the Nation objective. The increase in incidence had made it imperative that clinicians managing these patients keep up-to-date with the latest advances, allowing them to provide optimal treatment. As with many other cancers, management is both surgical and medical, and a major focus for new drug development. Inteferon is one such area of activity. FEATURES covers risk, prevention and screening discusses future therapies, e.g. vaccines covers options for advanced disease BENEFITS practical advice for risk management of interest to clinicians and researchers who and when to treat

Bibliografie na konci kap. - Věcný rejstřík